Different mechanisms in weight loss-induced blood pressure reduction between a calorie-restricted diet and exercise

Hypertension Research

Volumn 35, Issue 1, 2012, Pages 41-47

  Masuo, Kazuko ^a,b   Rakugi, Hiromi ^c   Ogihara, Toshio ^c   Lambert, Gavin W ^a,d  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b Nucleus Network Ltd   (Australia)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d MONASH UNIVERSITY   (Australia)

Author keywords

a calorie restricted diet; an aerobic exercise; insulin resistance; obesity; sympathetic nervous activity

Indexed keywords

LEPTIN; NORADRENALIN;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BLOOD PRESSURE REGULATION; BODY FAT; BODY MASS; BODY WEIGHT; CALORIC RESTRICTION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; EXERCISE; HEART RATE; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NORADRENALIN BLOOD LEVEL; PHYSICAL ACTIVITY; SALT INTAKE; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO; WEIGHT REDUCTION;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; DIET, REDUCING; EXERCISE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; MIDDLE AGED; NOREPINEPHRINE; OBESITY; WAIST-HIP RATIO; WEIGHT LOSS;

EID: 84855426429     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2011.134     Document Type: Article

References (59)

1. Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, Glannattasio C, Brunani A, Cavagnini F, Mancia G. Sympathetic activation in obese normotensive subjects. Hypertension 1995; 25(Pt 1): 560-563.
2. Grassi G. Role of the sympathetic nervous system in human hypertension. J Hypertens 1998; 16(Pt 2): 1979-1987. (Pubitemid 29002377)
3. Landsberg L. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens 2001; 15: 523-528. (Pubitemid 32280942)
4. Masuo K, Katsuya T, Fu Y, Rakugi H, Ogihara T, Tuck ML. 2-and b3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5. years. Circulation 2005; 111: 3429-3434. (Pubitemid 40923396)
5. Masuo K. Role of beta2-and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome. Int J Hypertens 2010; 2010: 832821.
6. Esler M, Kaye D. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol 2000; 35(Suppl 4): S1-S7.
7. Masuo K, Katsuya T, Sugimoto K, Kawaguchi H, Rakugi H, Ogihara T, Tuck ML. High plasma norepinephrine levels associated with beta2-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individuals. Hypertens Res 2007; 30: 503-511. (Pubitemid 47083120)
8. Ksiazek A, Zatuska W. Sympathetic overactivity in uremia. J Ren Nutr 2008; 18: 118-121. (Pubitemid 350251839)
9. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Stancanelli B, Malatino LS. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2002; 105: 1354-1359. (Pubitemid 34260428)
10. Berglund G, Nilsson P, Eriksson KF, Nilsson JA, Hedblad B, Kristenson H, Lindgrade F. Long-term outcome of the Malmo preventive project: mortality and cardiovascular morbidity. J Intern Med 2000; 247: 19-29. (Pubitemid 30073160)
11. National Heart, Lung and Blood Institute, National Institute of Health. The Seventh Report of the Joint National Committee on "Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). http://www.nhlbi.nih.gov/guidelines/hypertension/#status.
12. JSH 2009. JSH guideline for the management of hypertension. Hypertens Res 2009; 32: 11-23.
13. Hackam DG, Khan NA, Hemmelgrarn BR, Rabkin SW, Touyz RM, Campbell NR, Padwal R, Campbell TS, Lindsay MP, Hill MD, Quinn RR, Mahon JL, Herman RJ, Schiffrin EL, Ruzicka M, Larochelle P, Feldman RD, Lebel M, Poirier L, Arnold JM, Moe GW, Howlett JG, Trudeau L, Bacon SL, Petrella RJ, Milot A, Stone JA, Drouin D, Boulanger JM, Sharma M, Hamet P, Fodor G, Dresser GK, Carruthers SG, Pylypchuk G, Burgess ED, Burns KD, Vallée M, Prasad GV, Gilbert RE, Leiter LA, Jones C, Ogilvie RI, Woo V, McFarlane PA, Hegele RA, Tobe SW;. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2-therapy. Can J Cardiol 2010; 26: 249-258.
14. Goodpaster BH, Delany JP, Otto AD, Kuller L, Vockley J, South-Paul JE, Thomas SB, Brown J, McTigue K, Hames KC, Lang W, Jakicic JM. Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. JAMA 2010; 304: 1795-1802.
15. Miller III ER, Erlinger TP, Young DR, Jehn M, Charleston J, Rhodes D, Wasan SK, Appel LJ. Results of the diet, exercise, and weight loss intervention trial (DEW-IT). Hypertension 2002; 40: 612-618. (Pubitemid 35278595)
16. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a metaanalysis of randomized, controlled trials. An Intern Med 2002; 136: 493-503. (Pubitemid 34252283)
17. Blumenthal JA, Babyak MA, Sherwood A, Craighead L, Lin PH, Johnson J, Watkins LL, Wang JT, Kuhn C, Feinglos M, Hinderliter A. Effects of dietary approaches to stop hypertension diet alone and in combination with exercise and caloric restriction on insulin sensitivity and lipids. Hypertension 2010; 55: 1199-1205.
18. Smith PJ, Blumenthal JA, Babyak MA, Craighead L, Welsh-Bohmer KA, Browndyke JN, Strauman TA, Sherwood A. Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure. Hypertension 2010; 55: 1331-1336.
19. Himderliter AL, Babyak MA, Sherwood A, Blumenthal JA. The DASH diet and insulin sensitivity. Curr Hypertens Rep 2011; 13: 67-73.
20. Masuo K, Mikami H, Ogihara T, Tuck ML. Weight reduction and pharmacological treatment in obese hypertensives. Am J Hypertens 2001; 14(Pt 1): 530-538. (Pubitemid 32506726)
21. Claesson IM, Josefsson A, Sydsjo G. Prevalence of anxiety and depressive symptoms among obese pregnant and postpartum women: an intervention study. BMC Public Health 2010; 10: 766.
22. Adesseun GA, Rosas SE. The impact of obstructive sleep apnea on chronic kidney disease. Curr Hypertens Rep 2010; 12: 378-383.
23. Masuo K, Mikami H, Ogihara T, Tuck ML. Weight gain-induced blood pressure elevation. Hypertension 2000; 35: 1135-1140. (Pubitemid 30327270)
24. Lambert GW, Masuo K, Dixon JB. Weight loss in obesity and metabolic syndrome. Curr Hypertens Rev 2011; 6: 130-138.
25. Yokoyama H, Emoto M, Fujiwara S, Motoyama K, Morioka T, Komatsu M, Tahara H, Shoji T, Okuno Y, Nishizawa Y. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients. Diabetes Care 2003; 26: 2426-2432. (Pubitemid 36993338)
26. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 1999; 282: 1519-1522. (Pubitemid 29504044)
27. Lee DS, Chiu M, Manuel DG, Tu K, Wang X, Austin PC, Mattern MY, Mitiku TF, Svenson LW, Putnam QW, Flanagan WM, Tu JV. Trends in risk factors for cardiovascular disease in Canada: temporal, socio-demographic and geographic factors. CMAJ 2009; 191: E55-E66.
28. Mokdad AH, Ford ES, Bowman BA, Diez WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-79. (Pubitemid 36026281)
29. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FS, Giannattasio C, Grassi G, Sega R. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population. J Hypertens 2008; 26: 1602-1611.
30. Cameron AJ, Dustan DW, Owen N, Zimmet PZ, Barr EL, Tonkin AM, Magliano DJ, Murray SG, Welborn TA, Shaw JE. Health and mortality consequences of abdominal obesity: evidence from the AusDiab study. Med J Aust 2009; 191: 202-208.
31. Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Am Intern Med 2005; 142: 611-619. (Pubitemid 40529957)
32. Anderssen SA, Carroll S, Urdal P, Holme I. Combined diet and exercise intervention reverses the metabolic syndrome in middle-aged males: results from the Oslo Diet and Exercise Study. Scand J Med Sci Sports 2007; 17: 687-695.
33. Poobalan AS, Aucott LS, Smith WCS, Avenell A, Jung R, Broom J. Long-term weight loss effects on all cause mortality in overweight/obese populations. Obes Rev 2007; 8: 503-513. (Pubitemid 47628490)
34. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC. Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357: 753-761. (Pubitemid 47295642)
35. Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, Proietto J, Bailey M, Anderson M. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008; 299: 316-323. (Pubitemid 351159368)
36. Lambert E, Straznicky N, Schlaich MP, Esler M, Dawood T, Hotchkin E, Lambert G. Different pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension 2007; 50: 862-868. (Pubitemid 350287527)
37. Straznicky NE, Grima MT, Lambert EA, Eikelis N, Dawood T, Lambert GW, Nestle PJ, Masuo K, Sari CI, Chopra R, Mariani JA, Schlaich MP. Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals. J Hypertens 2011; 29: 553-564.
38. Esler M, Jennings G, Lambert G. Noradrenaline release and the patho-physiology of primary human hypertension. Am J Hypertens 1989; 2: S140-S146.
39. Gosmanov AR, Smiley DD, Robalino G, Siquiera J, Khan B, Le NA, Patel RS, Quyyumi AA, Peng L, Kitabchi AE, Umpierrez GE. Effects of oral and intravenous fat load on blood pressure, endothelial function, sympathetic activity, and oxidative stress in obese healthy subjects. Am J Physiol Endocrinol Metab 2010; 299: E953-E958.
40. Masuo K, Katsuya T, Ogihara T, Tuck ML. Acute hyperinsulinemia reduces plasma leptin levels in insulin-sensitive Japanese men. Am J Hypertens 2005; 18(2 Pt 1): 235-243. (Pubitemid 40332554)
41. Straznicky N, Lambert GW, Masuo K, Dawood T, Eikelis N, Nestel PJ, McGrane MT, Mariani JA, Socratous F, Chopra R, Esler MD, Schlaich MP, Lambert EA. Blunted sympathetic neural response to oral glucose in obesity subjects with the insulinresistant metabolic syndrome. Am J Clin Nutr 2009; 89: 27-36.
42. Masuo K, Mikami H, Ogihara T, Tuck ML. Differences in mechanisms between weight loss-sensitive and-resistant blood pressure reduction in obese subjects. Hypertens Res 2001; 24: 371-376. (Pubitemid 32792437)
43. Sowers JR, Nyby M, Stern N, Beck F, Baron S, Catania R, Vlachis N. Blood pressure and hormone changes associated with weight reduction in the obese. Hypertension 1982; 4: 686-691. (Pubitemid 13239687)
44. Maxwell MH, Heber D, Waks AU, Tuck ML. Role of insulin and norepinephrine in the hypertension of obesity. Am J Hypertens 1994; 7: 402-408. (Pubitemid 24170529)
45. Masuo K, Ogihara T. Mechanisms in obesity-related hypertension in humans. Hypertension 2000; 36(Suppl 2): 17 (Proceeding for Jackson Cardiovascular Renal Meeting).
46. Gohler L, Hahnemann T, Michael N, Oehme P, Steglich HD, Conradi E, Grune T, Siems WG. Reduction of plasma catecholamines in humans during clinically controlled severe underfeeding. Prev Med 2000; 30: 95-102. (Pubitemid 30094241)
47. Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler MD, Nestle PJ. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab 2005; 90: 5998-6005. (Pubitemid 41606517)
48. Sivitz WI, Fink BD, Morgan DA, Fox JM, Donohouse PA, Haynes WG. Sympathetic inhibition, leptin, and uncoupling protein subtype expression in normal fasting rats. Am J Physiol 1999; 277(Pt 1): E668-E677. (Pubitemid 29522619)
49. Meredith IT, Friberg P, Jennings GL, Dewar EM, Fazio VA, Lambert GW, Esler MD. Exercise training lowers resting renal but not cardiac sympathetic activity in humans. Hypertension 1991; 18: 575-582.
50. Masuo K, Ogihara T, Kumahara Y, Yamatodani A, Wada H. Plasma norepinephrine and dietary sodium intake in normal subjects and patients with essential hypertension. Hypertension 1983; 5: 767-771. (Pubitemid 14230779)
51. Maxwell MH, Kushiro T, Dornfeld LP, Tuck ML, Waks AU. BP changes in obese hypertensive subjects during rapid weight loss. Comparison of restricted v unchanged salt intake. Arch Intern Med 1984; 144: 1581-1584.
52. Straznicky NE, Lambert EA, Nestel PJ, McGrane MT, Dawood T, Schlaich MP, Masuo K, Eikelis N, de Courten B, Mariani JA, Esler MD, Socratous F, Chopra R, Sari CI, Paul E, Lambert GW. Sympathetic neural adaptation in hypocaloric diet with or without exercise training in obese metabolic syndrome subjects. Diabetes 2010; 50: 71-79.
53. Blumenthal JA, Babyak MA, Hinderliter A, Watkins LL, Craighead L, Lin PH, Caccia C, Johnson J, Waugh R, Sherwood A. Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med 2010; 170: 126-135.
54. Strazanicky NE, Grima MT, Lambert EA, Eikelis N, Dawood T, Lambert GW, Nestel PJ, Masuo K, Sari CI, Chopra R, Mariani JA, Schlaich MP. Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals. J Hypertens 2011; 29: 553-564.
55. Pescatello LS, Blanchard BE, Van Heest JL, Maresh CM, Gordish-Dressman H, Thompson PD. The metabolic syndrome and the immediate antihypertensive effects of aerobic exercise: a randomised control design. BMC Cardiovascular Disorders 2008; 8: 12 doi:10.1186/1471-2261-8-12. (Pubitemid 351943431)
56. Straznicky NE, Lambert GW, McGrane MT, Masuo K, Dawood T, Nestel PJ, Eikelis N, Schlaich MP, Esler MD, Socratous F, Chopra R, Lambert EA. Weight loss may reverse blunted sympathetic neural responsiveness to glucose ingestion in obese subjects with metabolic syndrome. Diabetes 2009; 58: 1126-1132.
57. Ribeiro MM, Silva AG, Santos NS, Guazzelle I, Matos LN, Trombetta IC, Halpern A, Negrao CE, Villares SM. Diet and exercise training restore blood pressure and vasodilatory responses during physiological maneuvers in obese children. Circulation 2005; 111: 1915-1923. (Pubitemid 40575729)
58. Trombetta IC, Batalha LT, Rondon MU, Laterza MC, Kuniyoshi FH, Gowdak MM, Barretto AC, Halpern A, Villares SM, Negrao CE. Weight loss improves neurovascular and muscle metaboreflex control in obesity. Am J Physiol Heart Circ Physiol 2003; 11: H974-H982. (Pubitemid 37048150)
59. Tonacio AC, Trombetta IC, Rondon MU, Batalha LT, Kuniyoshi FH, Laterza MC, Suzuki PH, Gowdak MM, Barretto AC, Halpern A, Villares SM, Negrao CE. Effects of diet and exercise training on neurovascular control during mental stress in obese women. Braz J Med Biol Res 2006; 39: 53-62. (Pubitemid 43091528)